Internal Medicine, Gastroenterology · Albuquerque, NM
NPI
1780996439
Since 2010
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1100 Lead Ave SE
Albuquerque, NM, 87106
Phone (505) 224-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
734 services
Medicare patients, 2024
399
Average age 71
Drug cost, 2024
$1.3M
2,641 prescriptions
Company payments, 2025
$454
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vipin Mittal was code 45385 (colonoscopy - lesion removal), 140 times for 139 patients. In total Vipin Mittal billed 734 services in 45 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 140 | 139 | $196.74 | $28K |
| 43239 Upper GI Endoscopy | Facility | 96 | 94 | $53.34 | $5,121 |
| 99214 Office E&M - Established | Facility | 90 | 73 | $70.48 | $6,343 |
| 45380 Lower GI Endoscopy - Other | Facility | 86 | 86 | $72.79 | $6,260 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 75 | 74 | $2.71 | $203 |
| 91200 Standard X-ray | Facility | 42 | 42 | $7.80 | $327 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 27 | 27 | $172.24 | $4,651 |
| 43249 Upper GI Endoscopy | Facility | 21 | 21 | $91.59 | $1,923 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 18 | 18 | $171.41 | $3,085 |
| 99213 Office E&M - Established | Facility | 16 | 15 | $44.13 | $706 |
| 99215 Office E&M - Established | Facility | 15 | 15 | $97.04 | $1,456 |
By year: 2022 $64K for 726 services; 2023 $64K for 737 services; 2024 $68K for 734 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vipin Mittal prescribed most often to Medicare patients was Omeprazole, with 456 prescriptions and refills. In total Vipin Mittal wrote 2,641 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 456 | 1,169 | 170 | $6,940 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 431 | 431 | 416 | $8,981 |
| Famotidine Generic | 275 | 690 | 109 | $4,433 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 215 | 215 | 208 | $3,867 |
| Pantoprazole Sodium Generic | 180 | 455 | 61 | $3,627 |
| Dicyclomine Hcl Generic | 79 | 136 | 36 | $2,654 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 69 | 69 | 66 | $1,948 |
| Ursodiol Generic | 58 | 147 | 16 | $5,787 |
| Furosemide Generic | 54 | 142 | 19 | $551 |
| Lactulose Generic | 54 | 71 | 20 | $2,758 |
| Mesalamine Generic | 42 | 66 | Under 11 | $17K |
| Linzess Linaclotide | 41 | 81 | Under 11 | $43K |
| Sodium Chloride 0.9 % Sodium Chloride | 41 | 41 | Under 11 | $1,263 |
| Budesonide Dr Budesonide | 33 | 63 | 17 | $2,180 |
| Spironolactone Generic | 33 | 97 | 14 | $767 |
Brand drugs: - claims; generic drugs: 2,060 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vipin Mittal $454 ($454 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $454.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $454 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.